In addition, dysregulation of GSK3β affects Aβ, tau protein phosphorylation, synaptic plasticity, and other signaling pathways are involved in the pathogenesis of AD (Lauretti et al. 2020). This evidence concerns the gene GSK3B and Alzheimer disease.